ET
GH icon

Entropy Technologies’s Guardant Health GH Stock Holding History

Entropy Technologies’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$819K Sell
5,461
-675
-11% -$73.4K 0.03% 558
2026
Q1 		$567K Sell
6,136
-10,957
-64% -$1.1M 0.03% 561
2025
Q4 		$1.75M Buy
17,093
+9,979
+140% +$893K 0.09% 276
2025
Q3 		$444K Sell
7,114
-4,020
-36% -$219K 0.03% 551
2025
Q2 		$579K Buy
11,134
+6,087
+121% +$272K 0.05% 437
2025
Q1 		$215K Sell
5,047
-7,299
-59% -$315K 0.02% 614
2024
Q4 		$377K Buy
+12,346
New +$347K 0.04% 491

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Entropy Technologies's GH Position: Q2 2026 in Review

Entropy Technologies reduced its Guardant Health (GH) stake by 11% in Q2 2026, selling an estimated $73.4K and leaving 5,461 shares worth $819K. The position accounts for 0.03% of the portfolio, ranked #558.

Entropy Technologies first reported a position in GH in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.75M in Q4 2025. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Entropy Technologies held 5,461 shares of Guardant Health worth $819K as of Q2 2026.
  • Entropy Technologies sold 675 Guardant Health shares in Q2 2026, an estimated $73.4K.
  • Guardant Health made up 0.03% of Entropy Technologies's portfolio in Q2 2026, its #558 holding.
  • Entropy Technologies first reported a position in Guardant Health in Q4 2024 and has held it in 7 quarters since.
  • Entropy Technologies's Guardant Health position peaked at $1.75M in Q4 2025.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Entropy Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.